Air Filter with `Catch and Kill` Technology Eliminates Airborne Viruses, Including COVID-19 Variants
The only air filter in the world proven to "catch and kill" airborne COVID-19, Anthrax spores, bacteria, allergens, and other asthma triggers was launched at the 2022 Consumer Electronics Show (CES). More...07 Jan 2022
Unique Antibody-Like Proteins Derived from Immune Systems of Sharks Can Prevent COVID-19 Virus and Its Variants
Small, unique antibody-like proteins known as VNARs - derived from the immune systems of sharks - can prevent the virus that causes COVID-19, its variants, and related coronaviruses from infecting human cells, according to a new study. More...31 Dec 2021
Discovery of Omicron Neutralizing Antibodies Could Lead to Effective Treatments for COVID-19 Variants
An international team of scientists have identified antibodies that neutralize Omicron and other SARS-CoV-2 variants, raising hopes of the findings leading to the development of more effective vaccines and antibody treatments for COVID-19 variants. More...29 Dec 2021
World’s First Molecular-Level Analysis of Omicron Spike Protein to Help Develop Variant-Resistant COVID-19 Treatments
Scientists have unveiled the world’s first molecular-level analysis of the Omicron variant spike protein, revealing strong antibody evasion and binding with human cells that contribute to its increased transmissibility. More...27 Dec 2021
Merck and Ridgeback’s Oral Antiviral Receives US FDA EUA for Treatment of COVID-19 in Certain Adults
Merck (Kenilworth, NJ, USA) and Ridgeback Biotherapeutics (Miami, FL, USA) have been granted Emergency Use Authorization (EUA) by the US Food and Drug Administration (FDA) for molnupiravir, an investigational oral antiviral (MK-4482, EIDD-2801). More...24 Dec 2021
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
12-Channel ECG
CM1200B
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Examination Data Management Software
DiVAS 2.8
In Other News
Pfizer’s Paxlovid Becomes First Oral COVID Antiviral Drug to Receive US FDA EUA
Blood Markers Linked to Severe COVID-19 Could Pave Way for Simple Diagnostic Tests
Innovative X-Ray Imaging Showing COVID-19 Vascular Damage Could Support Routine Lab Diagnostics
Study Reveals New Imaging Findings in Patients with Breakthrough COVID-19 Infections
Regeneron’s Next-Gen COVID-19 Monoclonal Antibodies Active Against All Known VOCs, Including Omicron and Delta
New AI Model Based on 3D CT Scans Improves Accuracy of Machine Learning in COVID-19 Diagnosis
Respiratory Discovery Could Improve Survival of COVID-19 Intensive Care Patients
Pfizer's COVID-19 Pill Nearly 90% Effective and Shows Potency Against Omicron Variant
New Diagnostic Combines Fast Imaging Hardware with Data Analysis to Indicate Blood Clotting in COVID-19 Patients
New AI Tool to Help Combat Future COVID Variants
Novel Extracorporeal Oxygenation System Could Become First Respiratory Device to Substitute Mechanical Ventilation
World’s First Single Exposure Portable Dual-Energy X-Ray Detector Identifies 25% More Cases of Pneumonia, Including COVID-19
New AI Technology Helps Hospitals Identify COVID-19 Patients Who Require ICU Treatment
Deep Learning-Powered Automated System Detects COVID-19 Lesions by Analyzing CT Chest Scans
New Algorithm Reads Data from Smartwatches to Alert Wearers to Bodily Stress, Including COVID-19
SARS-CoV-2 Blood Biomarker Identifies Infected Patients Most at Risk of Dying of COVID-19
First-Ever Molecules that Target SARS-CoV-2 RNA and Prevent Replication Could Cure COVID-19
New Algorithm Identifies COVID-19 Patients Who Will Require Intensive Care or Ventilation With 90% Accuracy
Deep Learning Neural Network Quickly Detects COVID-19 Infections Using X-Ray Images
New Test Measures Both T-Cell and Antibody Response to SARS-CoV-2 in Single Blood Sample
Same Day DNA Sequencing-Based Test Identifies Secondary Infections in COVID-19 Patients
AI Combined with Genomic Surveillance Beats Humans at Detecting Infectious Disease Outbreaks in Hospital Settings
Inappropriate Diagnostic Tests Could Overestimate SARS-CoV-2 Infections Among Vaccinated People
